BBPvsBBCETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) and Virtus LifeSci Biotech Clinical Trials ETF (BBC) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.65% for BBC. BBP is up 21.54% year-to-date (YTD) with +$40M in YTD flows. BBC performs better with 28.23% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of BBP and BBC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs BBC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP BBC | +0.94%-5.49% | +15.67%+8.79% | +21.54%+28.23% | +56.59%+126.14% | +81.31%+122.92% | +94.15%+14.49% |
| Flows | BBP BBC | +$10M+$83K | +$28M+$5M | +$40M+$5M | +$52M+$11M | +$55M+$15M | +$48M+$6M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP BBC | +26.32%+38.48% | +24.02%+35.85% | +24.33%+37.04% | +26.47%+39.65% |
| Max drawdown | BBP BBC | -7.49%-11.52% | -9.59%-14.64% | -25.54%-54.25% | -37.61%-70.93% |
| Max drawdown duration | BBP BBC | 44d44d | 48d60d | 292d340d | 586d1754d |
Trading data
BBP | BBC | |
Last sale 7/28/2026 at 1:30 PM | $97.69 | $48.85 |
| Previous close 07/27/2026 | $97.26 | $49.74 |
| Consolidated volume 07/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | BBC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
BBP | BBC | |
|---|---|---|
| Last price | $97.69 | $48.85 |
| 1D performance | +0.45% | -1.79% |
| AuM | $96.94 M | $47.12 M |
| E/R | 0.34% | 0.65% |
Characteristics
BBP | BBC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | VIRTUS Investment Partners |
| Benchmark | LifeSci Biotechnology Products Index | LifeSci Biotechnology Clinical Trials Index |
| N° of holdings | 66 | 125 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
89.11%
Other
10.89%
BBC
USA
85.4%
Other
14.6%
Sectors
BBP
Healthcare
89.47%
Other
10.53%
BBC
Healthcare
95.19%
Other
4.81%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
87.15%
BBC
Total weight of top 15 holdings out of 15
14.01%
Top 15 holdings
Data as of June 30, 2026
BBP
Verastem, Inc.
44.58%
Legend Biotech Corp.
41.98%
Agios Pharmaceuticals, Inc.
0.05%
BioCryst Pharmaceuticals, Inc.
0.05%
BioMarin Pharmaceutical, Inc.
0.05%
Rigel Pharmaceuticals, Inc.
0.05%
Crinetics Pharmaceuticals, Inc.
0.05%
Madrigal Pharmaceuticals, Inc.
0.05%
BioNTech SE
0.05%
Iovance Biotherapeutics, Inc.
0.05%
Rhythm Pharmaceuticals, Inc.
0.05%
Alnylam Pharmaceuticals, Inc.
0.05%
Incyte Corp.
0.05%
Sarepta Therapeutics, Inc.
0.05%
Omeros Corp.
0.05%
BBC
uniQure NV
1.18%
REGENXBIO, Inc.
1.01%
Apogee Therapeutics, Inc.
0.99%
Monopar Therapeutics, Inc.
0.97%
Jade Biosciences, Inc.
0.94%
Aktis Oncology, Inc.
0.94%
MBX Biosciences, Inc.
0.94%
Biohaven Ltd.
0.90%
Kymera Therapeutics, Inc.
0.89%
Cullinan Therapeutics, Inc.
0.89%
SELLAS Life Sciences Group, Inc.
0.89%
Generate Biomedicines, Inc.
0.88%
Nurix Therapeutics, Inc.
0.87%
Intellia Therapeutics, Inc.
0.87%
4D Molecular Therapeutics, Inc.
0.86%
Frequently asked questions about BBP and BBC
How have the BBP and BBC ETFs performed in 2026?
As of July 27, 2026, BBP is up 21.54% year-to-date (YTD), while BBC has returned 28.23%. That puts BBC better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or BBC?
Year-to-date, the BBP ETF saw +$40M in flows, compared to +$5M for BBC.
Which ETF is more volatile: BBP or BBC?
Over the past year, BBP had a volatility of 24.02%, while BBC experienced 35.85%.
Which ETF is bigger: BBP or BBC?
As of July 27, 2026, BBP holds $96.94 M in assets under management (AUM), while BBC manages $47.12 M.
What sectors do the BBP and BBC ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, BBC focuses on Healthcare.
What are the top holdings of the BBP ETF and BBC ETF?
BBP top holdings include Verastem, Inc., Legend Biotech Corp. and Agios Pharmaceuticals, Inc.. BBC holds in its top three: uniQure NV, REGENXBIO, Inc. and Apogee Therapeutics, Inc..
Which ETF is more diversified: BBP or BBC?
BBP holds 66 securities with 87.15% of its assets in the top 15. BBC has 125 securities and a top 15 weight of 14.01%.
Advertisement
Latest news about BBP & BBC
Advertisement
